TREM2 variants have been associated with increased risk of developing AD (Sims et al., 2017; Carmona et al., 2018) as well as FTD and other neurodegenerative diseases (Guerreiro et al., 2013a,b; Yeh et al., 2017). The gene discussed is TREM2; the disease is Alzheimer disease.